Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curtis, J. J.
Right arrow Articles by Luke, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtis, J. J.
Right arrow Articles by Luke, R. G.

Journal of the American Society of Nephrology, Vol 3, 1570-1574, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Captopril-induced fall in glomerular filtration rate in cyclosporine- treated hypertensive patients

JJ Curtis, DA Laskow, PA Jones, BA Julian, RS Gaston and RG Luke
Department of Medicine, University of Alabama, Birmingham 35294-0007.

It was found that two known renal vasodilators had different effects on RBF and GFR in the setting of therapeutic blood levels of cyclosporine in hypertensive renal transplant patients. Captopril lowered blood pressure in these patients but also lowered blood flow and GFR. Nifedipine lowered blood pressure to the same degree but without lowering either RBF or GFR.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
B. F. Palmer
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 1973 - 1975.
[Full Text] [PDF]

Home page
 NEJMHome page
B. F. Palmer
Renal Dysfunction Complicating the Treatment of Hypertension
N. Engl. J. Med., October 17, 2002; 347(16): 1256 - 1261.
[Full Text] [PDF]

Home page
 HypertensionHome page
M. Hausberg, M. Barenbrock, H. Hohage, S. Muller, S. Heidenreich, and K.-H. Rahn
ACE Inhibitor Versus ß-Blocker for the Treatment of Hypertension in Renal Allograft Recipients
Hypertension, March 1, 1999; 33(3): 862 - 868.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. Sennesael, J. Lamote, I. Violet, S. Tasse, and D. Verbeelen
Comparison of Perindopril and Amlodipine in Cyclosporine-Treated Renal Allograft Recipients
Hypertension, September 1, 1995; 26(3): 436 - 444.
[Abstract] [Full Text]

Home page
 HypertensionHome page
M. R. van der Schaaf, R. J. Hene, M. Floor, P. J. Blankestijn, and H. A. Koomans
Hypertension After Renal Transplantation : Calcium Channel or Converting Enzyme Blockade?
Hypertension, January 1, 1995; 25(1): 77 - 81.
[Abstract] [Full Text]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673